InMed Pharmaceuticals (INM) Share-based Compensation Growth (1y) (2020 - 2026)
InMed Pharmaceuticals (INM) Share-based Compensation Growth (1y) (2020 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Stock Comp. Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn | 26.47% |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn | 47.06% |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn | 6.60% |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn | -133.31% |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn | 8.33% |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn | 40.00% |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn | 59.27% |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn | 48.29% |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn | -24.33% |
| 10 | InMed Pharmaceuticals | 6.04 Mn | 796,124.14 | - | 2,381.83% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 2,381.83% |
| Dec 31, 2025 | 10.38% |
| Sep 30, 2025 | -30.24% |
| Jun 30, 2025 | -118.50% |
| Mar 31, 2025 | -98.84% |
| Dec 31, 2024 | 26.80% |
| Sep 30, 2024 | 14.98% |
| Jun 30, 2024 | -3.77% |
| Mar 31, 2024 | 9.83% |
| Dec 31, 2023 | -74.14% |
| Sep 30, 2023 | -78.41% |
| Jun 30, 2023 | -77.12% |
| Mar 31, 2023 | -74.19% |
| Dec 31, 2022 | -67.11% |
| Sep 30, 2022 | 4.98% |
| Jun 30, 2022 | -19.91% |
| Mar 31, 2022 | -5.89% |
| Dec 31, 2021 | 122.26% |
| Sep 30, 2021 | 30.13% |
| Jun 30, 2021 | 41.48% |